Pharmacokinetics of pelanserin in healthy volunteers. 1992

F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, D.F.

UI MeSH Term Description Entries
D008297 Male Males
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
January 1990, Archivos del Instituto de Cardiologia de Mexico,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
November 1988, Journal of clinical pharmacology,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
January 1990, Therapie,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
March 1999, European journal of clinical pharmacology,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
October 2005, Yao xue xue bao = Acta pharmaceutica Sinica,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
December 1983, The Journal of antimicrobial chemotherapy,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
February 1987, Journal of clinical pharmacology,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
January 1977, Acta pharmacologica et toxicologica,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
March 1982, The Journal of antimicrobial chemotherapy,
F J Flores-Murrieta, and J E Herrera, and G Castañeda-Hernández, and E Hong
January 1983, International journal of clinical pharmacology research,
Copied contents to your clipboard!